The effects of the long term treatment of harf dose peginterferon alpha-2a on iron metabolism for the chronic hepatitis C patients.

The effects of the long term treatment of harf dose peginterferon alpha-2a on iron metabolism for the chronic hepatitis C patients. - The long term treatment of harf dose peginterferon alpha-2a and iron metabolism

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002503

Enrollment

Registered

2009-11-01

Start date

2009-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic hepatitis with infected HCV

Interventions

with Pegylated interferon alfa 2a without Pegylated interferon alfa 2a

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: chronic hepatitis iwth HCV the patient,who did not get SVR by using PegIFN plus Ribavirin the patients, who did not administrate the treatment of PegIFN plus Ribavirin for their complication.

Exclusion criteria

Exclusion criteria: HCC liver failure intestibal pneumonia

Design outcomes

Primary

Measure	Time frame
improvement of iron metabolism	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026